- Home
- WRAP vs PYPD Comparison
WRAP vs PYPD Comparison
Compare WRAP & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WRAP | PYPD |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.7M | 86.6M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WRAP | PYPD |
|---|---|---|
| Price | $1.44 | $4.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $12.25 |
| AVG Volume (30 Days) | ★ 176.8K | 42.6K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,672,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $1.20 | $2.44 |
| 52 Week High | $3.23 | $5.12 |
Technical Indicators
Market Signals| Indicator | WRAP | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 51.49 |
| Support Level | $1.39 | $4.08 |
| Resistance Level | $1.60 | $4.65 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 15.91 | 48.14 |
Price Performance
Historical ComparisonAbout WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.